Vitura Health Limited engages in the sale and distribution of medicinal cannabis products in Australia. It operates through two segments: Sales and Distribution; and Clinics and Services. The company operates CanView, an online platform that delivers prescribing, dispensing, and medication management solutions for alternative therapies; Doctors on Demand, a premier provider of on-demand virtual healthcare services; BHC, an alternative therapy distributor; CDA Clinics, which provides medicinal consultations and prescription services; and Cannadoc, a medicinal cannabis clinic that offers telehealth consultations. It also offers psychedelics under the Cortexa brand; and Adaya which provides hybrid formulations and Australian-cultivated products. The company was formerly known as Cronos Australia Limited and changed its name to Vitura Health Limited in February 2023. Vitura Health Limited was incorporated in 2018 and is based in South Yarra, Australia.

Vitura Health Limited

Mr. Ben  Cirillo

Interim Chief Financial Officer

Mr. Ryan J. Tattle

Chief Revenue Officer

Mr. Geoff  Cockerill

Chief Executive Officer

Ms. Nicola  Swarbrick

Chief Operating Officer

Dr. Stefan  Schmidt

Chief Technology Officer

Ms. Erin  Leckie

Interim Head of Marketing

Ms. Deanna  Johns

Head of People & Culture

Mr. Jeffrey  Lerner

Head of Technology

Vitura Health Limited (VIT) Stock Analysis, Discussion Forum and Financial Metrics - ASX Exchange

VIT's latest dividend is 0.01 AUD on September 4, 2023

VIT Stock Discussion Forum and Message Board

News for ASX: VIT